BioTech/Drugs - N/A, N/A, US
We have been researching and developing state-of-the-art minimally invasive surgical methodologies for treating structural heart diseases like Tricuspid Valve Regurgitation (TR), Mitral Valve Regurgitation (MR), Hypertrophic Obstructive Cardiomyopathy (HOCM), and Heart arrhythmia.We are based in Busan, Korea, and having an office in Virginia, U.S. (Tau Cardio Inc.).We have finished first-in-man study of catheter-based annuloplasty mitral valve repair system, and started first-in-man study of RF ablation catheter for hypertrophic cardiomyopathy. And now we are actively preparing for global clinical trials with our catheter-based devices for TR, MR, HCM and heart arrhythmia.For more details, please visit our web site and refer the articles.
Nginx
YouTube
Mobile Friendly